DK0877803T3 - OB-proteinreceptor og relaterede sammensætninger og fremgangsmåder - Google Patents

OB-proteinreceptor og relaterede sammensætninger og fremgangsmåder

Info

Publication number
DK0877803T3
DK0877803T3 DK97901343T DK97901343T DK0877803T3 DK 0877803 T3 DK0877803 T3 DK 0877803T3 DK 97901343 T DK97901343 T DK 97901343T DK 97901343 T DK97901343 T DK 97901343T DK 0877803 T3 DK0877803 T3 DK 0877803T3
Authority
DK
Denmark
Prior art keywords
protein
methods
receptor
nucleic acids
receptors
Prior art date
Application number
DK97901343T
Other languages
English (en)
Inventor
Ming-Shi Chang
Andrew Avery Welcher
Frederick Addison Fletcher
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0877803T3 publication Critical patent/DK0877803T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK97901343T 1996-01-04 1997-01-02 OB-proteinreceptor og relaterede sammensætninger og fremgangsmåder DK0877803T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58282596A 1996-01-04 1996-01-04
US77441496A 1996-12-31 1996-12-31
PCT/US1997/000128 WO1997025424A1 (en) 1996-01-04 1997-01-02 Ob protein receptor and related compositions and methods

Publications (1)

Publication Number Publication Date
DK0877803T3 true DK0877803T3 (da) 2005-09-19

Family

ID=27078678

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97901343T DK0877803T3 (da) 1996-01-04 1997-01-02 OB-proteinreceptor og relaterede sammensætninger og fremgangsmåder

Country Status (11)

Country Link
EP (1) EP0877803B1 (da)
JP (1) JP2000502569A (da)
AT (1) ATE303437T1 (da)
AU (1) AU1526297A (da)
DE (1) DE69734096T2 (da)
DK (1) DK0877803T3 (da)
ES (1) ES2244990T3 (da)
IL (1) IL125081A (da)
NZ (1) NZ534416A (da)
PT (1) PT877803E (da)
WO (1) WO1997025424A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001968A (en) 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US6482927B1 (en) * 1995-11-27 2002-11-19 Millennium Pharmaceuticals, Inc. Chimeric proteins comprising the extracellular domain of murine Ob receptor
US6977240B1 (en) 1995-11-27 2005-12-20 Millenium Pharmaceuticals, Inc. Methods of using the OB receptor antibodies to treat bodyweight disorders
US7074397B1 (en) 1996-01-08 2006-07-11 Genentech, Inc. Method for enhancing proliferation or differentiation of a cell using ob protein
US20050019325A1 (en) 1996-01-08 2005-01-27 Carter Paul J. WSX receptor agonist antibodies
US6541604B1 (en) 1996-01-08 2003-04-01 Genentech, Inc. Leptin receptor having a WSX motif
US7063958B1 (en) * 1996-01-16 2006-06-20 The Rockefeller University Nucleic acids db, the receptor for leptin
US7084252B1 (en) 1996-01-16 2006-08-01 The Rockefeller University DB, the receptor for leptin
US7148004B1 (en) 1997-01-16 2006-12-12 The Rockefeller University Oligonucleotides of the OB-R isoforms and methods of diagnosing body weight
AU2476301A (en) * 1996-01-16 2001-05-24 Rockefeller University, The DB the receptor for leptin nucleic acids encoding the receptor, and uses thereof
US7619079B2 (en) 1996-02-14 2009-11-17 The Rockefeller University Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof
WO1997048419A1 (en) * 1996-06-20 1997-12-24 Merck & Co., Inc. Gene therapy for obesity
AU7821798A (en) * 1997-06-09 1998-12-30 Regeneron Pharmaceuticals, Inc. Assay systems for leptin-enhancing agents
US20030036114A1 (en) 1998-05-15 2003-02-20 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US6770444B2 (en) 1998-07-16 2004-08-03 Synaptic Pharmaceutical Corporation Methods of identifying or screening for agents that binds the Ob-Re
FR2836475B1 (fr) * 2002-02-26 2007-02-23 Aventis Pharma Sa Procede de detection de ligands du recepteur de la leptine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643748A (en) * 1994-09-14 1997-07-01 Progenitor, Inc. HU-B1.219, a novel human hematopoietin receptor
US6482927B1 (en) * 1995-11-27 2002-11-19 Millennium Pharmaceuticals, Inc. Chimeric proteins comprising the extracellular domain of murine Ob receptor
DE69734443T2 (de) * 1996-01-08 2006-07-13 Genentech, Inc., South San Francisco Ob-rezeptor und liganden
US7063958B1 (en) * 1996-01-16 2006-06-20 The Rockefeller University Nucleic acids db, the receptor for leptin
DK0892849T3 (da) * 1996-01-23 2006-07-24 Indevus Pharmaceuticals Inc Fremgangsmåde til anvendelse af obese-genet og dets genprodukt til stimulering af hæmatopoietisk udvikling

Also Published As

Publication number Publication date
AU1526297A (en) 1997-08-01
IL125081A0 (en) 1999-01-26
WO1997025424A1 (en) 1997-07-17
NZ534416A (en) 2005-12-23
ES2244990T3 (es) 2005-12-16
EP0877803A1 (en) 1998-11-18
DE69734096D1 (de) 2005-10-06
EP0877803B1 (en) 2005-08-31
IL125081A (en) 2006-08-01
JP2000502569A (ja) 2000-03-07
DE69734096T2 (de) 2006-06-29
PT877803E (pt) 2005-11-30
ATE303437T1 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
DK0877803T3 (da) OB-proteinreceptor og relaterede sammensætninger og fremgangsmåder
IL124831A0 (en) Ob protein derivatives having prolonged half-life
ATE277081T1 (de) Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
DK0733067T3 (da) N-terminalt kemisk modificerede proteinpræparater og fremgangsmåder
DE69836956D1 (de) Rezeptor 5, der eine für den zelltod verantwortliche domäne enthält
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
IL123189A0 (en) Colon cell and colon cancer cell associated nucleic acid molecules protein and peptides
ATE326478T1 (de) Peptidderivat
ATE323766T1 (de) Glykosylierte leptinzusammensetzungen und zugehörige verfahren
MXPA02008239A (es) Gen humano de la esquizofrenia.
MX9702789A (es) Novedosas proteinas ligandos del dominio de la muerte del receptor tnf, e inhibidores de la union delos ligandos.
BG103872A (en) Glycoconjugates of 20(s)-camptotecin
ATE271394T1 (de) Hybride zusammensetzungen für intrazellulaire verabreichung
HUT77029A (hu) A GAP-protein SH3 doménjéhez kötődni képes peptidek, ezeket kódoló nukleotidszekvenciák és előállításuk és alkalmazásuk
DK1009817T3 (da) RTD-receptor
SE9602822D0 (sv) New receptor
EP0815240A4 (en) NOVEL KINASE-LIKE CYCLINE-LIKE PROTEINS AND METHODS OF APPLICATION THEREOF
DE69637941D1 (de) Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
WO2001064876A3 (en) Human schizophrenia gene
CA2240394A1 (en) Ob protein receptor and related compositions and methods
ATE359263T1 (de) Substitutierte aminosaeuren als erythropoietin- mimetica
ATE407944T1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
SE9604439D0 (sv) New receptor
WO2000017363A3 (en) Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses